BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tschirner A, von Haehling S, Palus S, Doehner W, Anker SD, Springer J. Ursodeoxycholic acid treatment in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle 2012;3:31-6. [PMID: 22450540 DOI: 10.1007/s13539-011-0044-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Palus S, Elkina Y, Braun T, von Haehling S, Döhner W, Anker SD, Cerami A, Brines M, Springer J. The erythropoietin-derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle 2022. [PMID: 35586884 DOI: 10.1002/jcsm.13009] [Reference Citation Analysis]
2 Thibaut MM, Gillard J, Dolly A, Roumain M, Leclercq IA, Delzenne NM, Muccioli GG, Bindels LB. Bile Acid Dysregulation Is Intrinsically Related to Cachexia in Tumor-Bearing Mice. Cancers (Basel) 2021;13:6389. [PMID: 34945009 DOI: 10.3390/cancers13246389] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Feng L, Zhang W, Shen Q, Miao C, Chen L, Li Y, Gu X, Fan M, Ma Y, Wang H, Liu X, Zhang X. Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome. J Cachexia Sarcopenia Muscle 2021. [PMID: 34585527 DOI: 10.1002/jcsm.12798] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Thibaut MM, Sboarina M, Roumain M, Pötgens SA, Neyrinck AM, Destrée F, Gillard J, Leclercq IA, Dachy G, Demoulin JB, Tailleux A, Lestavel S, Rastelli M, Everard A, Cani PD, Porporato PE, Loumaye A, Thissen JP, Muccioli GG, Delzenne NM, Bindels LB. Inflammation-induced cholestasis in cancer cachexia. J Cachexia Sarcopenia Muscle 2021;12:70-90. [PMID: 33350058 DOI: 10.1002/jcsm.12652] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
5 de Sousa Cavalcante ML, Silva MS, Cavalcante AKM, de Oliveira Santos R, Nunes DDT, Busquets S, Argiles JM, Seelaender M, de Matos Neto EM, Dos Santos AA, da Silva MTB. Win 55,212-2, atenolol and subdiaphragmatic vagotomy prevent acceleration of gastric emptying induced by cachexia via Yoshida-AH-130 cells in rats. Eur J Pharmacol 2020;877:173087. [PMID: 32234430 DOI: 10.1016/j.ejphar.2020.173087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pötsch MS, Ishida J, Palus S, Tschirner A, von Haehling S, Doehner W, Anker SD, Springer J. MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia. J Cachexia Sarcopenia Muscle 2020;11:594-605. [PMID: 32067370 DOI: 10.1002/jcsm.12537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
7 Sun X, Feng X, Wu X, Lu Y, Chen K, Ye Y. Fat Wasting Is Damaging: Role of Adipose Tissue in Cancer-Associated Cachexia. Front Cell Dev Biol 2020;8:33. [PMID: 32117967 DOI: 10.3389/fcell.2020.00033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
8 Rohm M, Zeigerer A, Machado J, Herzig S. Energy metabolism in cachexia. EMBO Rep 2019;20:e47258. [PMID: 30890538 DOI: 10.15252/embr.201847258] [Cited by in Crossref: 35] [Cited by in F6Publishing: 54] [Article Influence: 11.7] [Reference Citation Analysis]
9 Li CX, Wang XQ, Cheng FF, Yan X, Luo J, Wang QG. Hyodeoxycholic acid protects the neurovascular unit against oxygen-glucose deprivation and reoxygenation-induced injury in vitro. Neural Regen Res 2019;14:1941-9. [PMID: 31290452 DOI: 10.4103/1673-5374.259617] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
10 Castellani C, Singer G, Kaiser M, Kaiser T, Huang J, Sperl D, Kashofer K, Fauler G, Guertl-lackner B, Höfler G, Till H. Neuroblastoma causes alterations of the intestinal microbiome, gut hormones, inflammatory cytokines, and bile acid composition: Castellani et al.. Pediatr Blood Cancer 2017;64:e26425. [DOI: 10.1002/pbc.26425] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
11 Saitoh M, Hatanaka M, Konishi M, Ishida J, Palus S, Ebner N, Döhner W, von Haehling S, Anker SD, Springer J. Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia. International Journal of Cardiology 2016;218:312-7. [DOI: 10.1016/j.ijcard.2016.05.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Musolino V, Palus S, Tschirner A, Drescher C, Gliozzi M, Carresi C, Vitale C, Muscoli C, Doehner W, von Haehling S, Anker SD, Mollace V, Springer J. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation. J Cachexia Sarcopenia Muscle 2016;7:555-66. [PMID: 27239419 DOI: 10.1002/jcsm.12116] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
13 Konishi M, Ebner N, von Haehling S, Anker SD, Springer J. Developing models for cachexia and their implications in drug discovery. Expert Opinion on Drug Discovery 2015;10:743-52. [DOI: 10.1517/17460441.2015.1041914] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
14 Konishi M, Pelgrim L, Tschirner A, Baumgarten A, von Haehling S, Palus S, Doehner W, Anker SD, Springer J. Febuxostat improves outcome in a rat model of cancer cachexia. J Cachexia Sarcopenia Muscle 2015;6:174-80. [PMID: 26136193 DOI: 10.1002/jcsm.12017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
15 von Haehling S, Anker SD. Treatment of cachexia: An overview of recent developments. International Journal of Cardiology 2015;184:736-42. [DOI: 10.1016/j.ijcard.2014.10.026] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
16 von Haehling S, Anker SD. Treatment of cachexia: an overview of recent developments. J Am Med Dir Assoc. 2014;15:866-872. [PMID: 25455531 DOI: 10.1016/j.jamda.2014.09.007] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
17 Elkina Y, Palus S, Tschirner A, Hartmann K, von Haehling S, Doehner W, Mayer U, Coats AJ, Beadle J, Anker SD, Springer J. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia. Int J Cardiol 2013;170:160-6. [PMID: 24207070 DOI: 10.1016/j.ijcard.2013.10.022] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
18 Palus S, von Haehling S, Flach VC, Tschirner A, Doehner W, Anker SD, Springer J. Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. International Journal of Cardiology 2013;168:3412-8. [DOI: 10.1016/j.ijcard.2013.04.150] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
19 Kalantar-Zadeh K, Rhee C, Sim JJ, Stenvinkel P, Anker SD, Kovesdy CP. Why cachexia kills: examining the causality of poor outcomes in wasting conditions. J Cachexia Sarcopenia Muscle 2013;4:89-94. [PMID: 23749718 DOI: 10.1007/s13539-013-0111-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
20 Anker MS, von Haehling S, Springer J, Banach M, Anker SD. Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Arch Med Sci 2013;9:166-71. [PMID: 23515589 DOI: 10.5114/aoms.2013.33356] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
21 Anker MS, von Haehling S, Springer J, Banach M, Anker SD. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. International Journal of Cardiology 2013;162:73-6. [DOI: 10.1016/j.ijcard.2012.10.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]